Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 7 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Jan 2026, Feb 2026, Mar 2026, May 2026 and Aug 2026.
- Largest single sale: $417K (17,250 shares) of Arcutis Biotherapeutics, Inc. on Nov 6, 2025. Filing
- Last sale before this period: Aug 21, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Medical Officer | Aug 5, 2020 | Aug 21, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 19, 2026, Arcutis Biotherapeutics, Inc.: sold 1,697 shares for $46K, to cover taxes. 1 filing: 1
- Aug 12, 2026, Arcutis Biotherapeutics, Inc.: sold 6,700 shares for $175K, no plan disclosed; 6,700 shares acquired by exercising options. 1 filing: 1
- Aug 11, 2026, Arcutis Biotherapeutics, Inc.: sold 8,300 shares for $220K, no plan disclosed; 8,300 shares acquired by exercising options. 1 filing: 1
- Aug 3, 2026, Arcutis Biotherapeutics, Inc.: sold 955 shares for $25K, under a disclosed plan. 1 filing: 1
- May 11, 2026, Arcutis Biotherapeutics, Inc.: sold 222 shares for $5K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.